Vivek Radhakrishnan
@drvivek_onco
Haemato-Oncologist & TCT Physician| Consultant & Haem trials lead, University Hospital Southampton| Passion: Immunotherapy & Precision medicine|
Views personal!
ID: 2592900127
28-06-2014 10:30:49
166 Tweet
469 Followers
336 Following
#BiSpecificMAbs are a breakthrough in the 💉of #lymphoma In an invited article we review the role of BsA in Indolent #lymphomas & posit different scenarios Andrew Davies LymphomaAction Blood Cancer UK Ankit kansagra Frontiers - Immunology #lymsm #drugdiscovery frontiersin.org/journals/immun…